Lindus Health

• 16/08/2023
• Series A
• $18,000,000

Our mission at Lindus Health is to accelerate clinical trials, so patients can benefit from new treatments sooner.

We are a next-gen CRO running radically faster, more reliable clinical trials for health and biotech pioneers. We do this thanks to a unique software platform, access to 20 million Electronic Health Records and a world-class clinical operation team. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management.

We have helped over 80 sponsors run entire clinical studies up to 3x faster than traditional CROs.

---

---